Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rank in Stocks #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Share Price
$2.16
Last synced: 2023-09-08
Market Cap
$122.36M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Pardes Biosciences, Inc. (PRDS)

Category

Price of PRDS with the market cap of B
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
PRDS
$2.16
Market Capitalization of Pardes Biosciences, Inc.(PRDS)
Market Cap: $122.36M
As of August 2026 Pardes Biosciences, Inc. has a market cap of $122.36M. This makes Pardes Biosciences, Inc. the world's 20774th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pardes Biosciences, Inc. from 2021 to 2026
PRDS compared with Top 5 Most Popular stocks
Price of PRDS Asset B Mkt. of B Results
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$91,999.27 $122.36M
$5.211T +4,259,125.30%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$80,266.30 $122.36M
$4.547T +3,715,932.38%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$73,482.56 $122.36M
$4.162T +3,401,870.44%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$63,425.58 $122.36M
$3.593T +2,936,269.59%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$49,303.85 $122.36M
$2.793T +2,282,485.64%